| Name | Age | Sex | DFSTD | Cancer type | Stage | FEV1 | PS | Treatment |
| DB | 73 | M | 32 | Adenocarcinoma | IIIb | ND | ND | Palliative treatment |
| JL | 76 | M | 32 | Adenocarcinoma | IV | ND | 3–4 | Palliative RT |
| SM | 67 | F | 36 | NSCLC | IV | ND | Poor | Palliative treatment |
| AE | 69 | F | 39 | Adenocarcinoma | IIb | 0.94 | 0 | Chemotherapy |
| RC | 61 | M | 45 | Adenocarcinoma | IIIa | 1.05 | 1 | Chemotherapy |
| RA | 61 | M | 59 | Mesothelioma | NA | ND | ND | Surgery (before diagnosis) |
| MF | 62 | F | 64 | SCLC | Ext | ND | 1 | Chemotherapy |
| DJ | 74 | M | 79 | NSCLC | IV | ND | ND | Palliative RT |
| JH | 86 | M | 92 | NSCLC | IV | ND | 4 | Palliative treatment |
| NK | 52 | M | 158 | NSCLC | IV | 3.38 | ND | Chemotherapy |
DFSTD, days from first seen to diagnosis; SCLC, small cell lung cancer; NSCLC, non-small cell lung cancer; ND, not documented; RT, radiotherapy.